The FDA has approved a new fibrinogen concentrate — fibrinogen, human-chmt (Fesilty, Grifols Therapeutics, LLC) — for the treatment of acute bleeding episodes in pediatric and adult patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback